Erik Magnusson

Capio AB provides medical, surgical, and psychiatric healthcare services. It operates through the following segments: Capio Nordic, Capio France, and Capio Germany. The Capio Nordic segment includes Capio Sweden, Capio Norway and Capio Denmark which consists of emergency, local and specialist hospitals, primary care and radiology centers. The Capio France segment comprises of emergency and local hospitals. The Capio Germany segment consists of general hospitals and outpatient clinics. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.

Part of ABG Sundal Collier Holding ASA, ABG Sundal Collier ASA provides brokerage services. The private company is based in Oslo, Norway. The Norwegian company was founded in 2001. Peter Straume has been the CEO of the company since 2020.

Systembolaget AB sells alcoholic products properly; and informs drinkers about the alcohol-related problems. It also offers non-alcoholic beverages and its products include liquor, wines, and beers. The firm provides information on the harmful effects of alcohol, as well. The company was founded on October 1, 1955 and is headquartered in Stockholm, Sweden.

Aleris Sjukvård AB provides healthcare services. It also offers elder care, psychiatry, health care, and medical diagnostic services. The firm operates specialist care centers, surgical units, local hospitals, senior care homes, nursing homes, home services, and rehabilitation centers. The company was founded in 2005 and is headquartered in Stockholm, Sweden.

SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn.

Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden.